Key Record Dates
ClinicalTrials.gov Identifier: | NCT03732950 |
---|---|
Brief Title: | Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer |
First Submitted : | November 5, 2018 |
First Submitted that Met QC Criteria : | November 5, 2018 |
First Posted : | November 7, 2018 |
Last Update Submitted that Met QC Criteria : | March 13, 2023 |
Last Update Posted : | March 15, 2023 |